Susquehanna International Group, LLP Iovance Biotherapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	BUY	$7.78 - $14.19 $1.71 Million - $3.12 Million	219,900 Added 28.58%	989,200 $7.93 Million
Q1 2024 May 07, 2024	SELL	$7.59 - $17.47 $1.39 Million - $3.2 Million	-183,400 Reduced 19.25%	769,300 $11.4 Million
Q4 2023 Feb 14, 2024	SELL	$3.3 - $8.89 $722,040 - $1.95 Million	-218,800 Reduced 18.68%	952,700 $7.75 Million
Q3 2023 Nov 14, 2023	BUY	$4.44 - $8.79 $3.89 Million - $7.71 Million	877,200 Added 298.06%	1,171,500 $5.33 Million
Q2 2023 Aug 11, 2023	BUY	$5.36 - $9.06 $792,744 - $1.34 Million	147,900 Added 101.02%	294,300 $2.07 Million
Q1 2023 May 16, 2023	BUY	$5.53 - $8.22 $351,155 - $521,970	63,500 Added 76.6%	146,400 $894,000
Q4 2022 Feb 14, 2023	SELL	$5.62 - $10.0 $341,134 - $607,000	-60,700 Reduced 42.27%	82,900 $529,000
Q3 2022 Nov 14, 2022	SELL	$9.53 - $13.11 $454,580 - $625,347	-47,700 Reduced 24.93%	143,600 $1.38 Million

323

239M

1.27M

1.68M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.48B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.